Kasuga Y, Matsubayashi S, Sakatsume Y, Miller N, Jamieson C, Volpé R
Endocrinology Research Laboratory, Wellesley Hospital, University of Toronto, Ontario, Canada.
J Endocrinol Invest. 1990 Dec;13(11):871-8. doi: 10.1007/BF03349645.
We have attempted to determine whether interferon gamma (IFN gamma) would enhance, sustain or induce autoimmune thyroid disease (AITD) in xenotransplanted thyroid tissue from patients with Graves' disease or normal persons (actually paranodular tissue) in nude athymic mice, in the absence of an intact immune system. A dosage of 4000 U/mouse of human IFN gamma (hIFN gamma) was injected intraperitoneally daily for six consecutive weeks into the xenotransplanted mice. The parameters measured included the free T4 index, thyroid autoantibodies and TSH during the course of hIFN gamma injections. Thyroid epithelial cell (TEC) HLA-DR expression was measured in the thyroid tissue before xenotransplantation and at sacrifice; in addition, light and electron microscopic studies were carried out at those times. There were no significant differences in thyroid function between the control results and those obtained with hIFN gamma in either group of tissues. TEC HLA-DR expression was significantly increased by hIFN gamma in the normal group, but insignificantly in the Graves' group. In both light and electron microscopic observations, Graves' tissue (whether or not treated with hIFN gamma) was indistinguishable at sacrifice from normal thyroid tissue. The appearance had markedly altered from the same Graves' tissue examined at the time of the initial human surgery, which then showed the usual histological appearance of this disorder. We conclude that IFN gamma induced HLA-DR expression alone is not sufficient to sustain the ongoing process of AITD in this model.(ABSTRACT TRUNCATED AT 250 WORDS)
我们试图确定,在缺乏完整免疫系统的情况下,干扰素γ(IFNγ)是否会增强、维持或诱发来自格雷夫斯病患者或正常人(实际上是甲状旁腺组织)的甲状腺组织在裸胸腺小鼠体内异种移植后的自身免疫性甲状腺疾病(AITD)。将4000 U/只小鼠的人IFNγ(hIFNγ)腹腔注射到异种移植小鼠体内,连续六周,每日一次。在注射hIFNγ的过程中,测量的参数包括游离T4指数、甲状腺自身抗体和促甲状腺激素(TSH)。在异种移植前和处死时测量甲状腺组织中甲状腺上皮细胞(TEC)的HLA-DR表达;此外,在这两个时间点进行光镜和电镜研究。两组组织中,对照组结果与hIFNγ处理组的甲状腺功能均无显著差异。hIFNγ使正常组的TEC HLA-DR表达显著增加,但在格雷夫斯病组中增加不显著。在光镜和电镜观察中,格雷夫斯病组织(无论是否用hIFNγ处理)在处死时与正常甲状腺组织无明显差异。其外观与最初人类手术时检查的同一格雷夫斯病组织相比有明显变化,当时该组织显示出这种疾病通常的组织学外观。我们得出结论,在该模型中,单独由IFNγ诱导的HLA-DR表达不足以维持AITD的持续进程。(摘要截短至250字)